SonoTarg has developed a new approach to targeted cancer therapy that enables physicians to specifically activate therapeutics at the site of tumour and minimise the adverse effects associated with conventional chemotherapy. The technology is based on research co-developed between the Universities of Ulster and Oxford and in close collaboration with leading clinicians at Belfast Hospitals. Read more at www.sonotarg.com
| Website | http://www.sonotarg.com |
| Employees | 11 (6 on RocketReach) |
| Founded | 2017 |
| Phone | +44 28 7044 9889 |
| Industry | Hospitals and Health Care, Pharmaceuticals, Healthcare |
| Keywords | Targeted Cancer Therapy, Tumor Targeting, Cancer Therapeutics, Targeted Drug Delivery, Cancer Treatment, Precision Medicine, Oncology, Drug Delivery, Chemotherapy, Advanced Drug Delivery, Minimally Invasive Therapy, Cancer Research, Biotechnology, Medical Technology, Drug Development, Pharmaceutical |
| Competitors | Siemens, AstraZeneca, Varian, Elekta, Accuray, INSIGHTEC, Sonic Healthcare, Theranova, LLC, Navidea Biopharmaceuticals, Targovax ASA +43 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular SonoTarg Ltd employee's phone or email?
Nigel Trim is the CEO of SonoTarg Ltd.
6 people are employed at SonoTarg Ltd.
SonoTarg Ltd is based in Belfast, Northern Ireland.
The NAICS codes for SonoTarg Ltd are [32, 325].
The SIC codes for SonoTarg Ltd are [283, 28].